A. Gonçalves

MOVIE: a phase I, open-label, multicenter study to evaluate the safety and tolerability of metronomic vinorelbine combined with durvalumab plus tremelimumab in patients with advanced solid tumors

C. Vicier, J. Ciccolini, N. Isambert, 2022, ESMO open.

213MO Primary endpoint analysis of a randomized phase II of darolutamide or capecitabine in patients with triple-negative androgen receptor-positive advanced breast cancer (UCBG3-06 START trial)

G. MacGrogan, H. Bonnefoi, O. Trédan, 2022, Annals of Oncology.

NONINVASIVE BREATH TESTS FOR DIAGNOSIS OF SIBO AND LACTOSE INTOLERANCE IN PATIENTS ON CHEMOTHERAPY TREATMENT FOR COLORECTAL AND GASTRIC CÂNCER.

N. Forones, O. Ambrogini, A. Gonçalves, 2021, Arquivos de gastroenterologia.

58O Safety interim analysis (SIA) of the phase III postneoadjuvant SASCIA study evaluating sacituzumab govitecan (SG) in patients with primary HER2-negative breast cancer (BC) at high relapse risk after neoadjuvant treatment

C. Denkert, F. Marmé, J. Blohmer, 2022, Annals of Oncology.